The Final Verdict on GLP-1 Patches GLP-1 patches represent a very exciting future for medicine, promising a more convenient, needle-free way to manage weight and metabolic health
Vendors unwilling to provide documentation warrant skepticism
The convergence of GLP-1 signaling with pathways of aginginsulin sensitivity, mitochondrial function, neuroinflammationsuggests these drugs may influence healthspan, not just body weight. (de Cabo & Mattson, 2019) For women entering their 50s and 60s, this convergence is especially powerful
As the membranes sustain oxidative damage, the mitochondria lose their ability to efficiently pump protons and generate ATP
Crdova B, Morat R, Izquierdo D, Paramio T, Mogas T
Semaglutide retains full agonist potency at the GLP-1 receptor, EC50 values for cAMP accumulation are comparable to native GLP-1, while showing negligible affinity for the GIP receptor or other class B GPCRs